<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398165/" ref="ordinalpos=1210&amp;ncbi_uid=5428403&amp;link_uid=PMC3398165" image-link="/pmc/articles/PMC3398165/figure/F4/" class="imagepopup">Figure 4.  From: Remarkable inhibition of mTOR <span class="highlight" style="background-color:">signaling</span> by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells. </a></div><br /><div class="p4l_captionBody">Proposed scheme for the inhibition of both arms of the mTOR pathway by p-XSC and rapamycin in C4-2 cells. Rapamycin inhibits mTORC1 signaling while p-XSC inhibits mTORC2 signaling. p-XSC treatment may offset feedback activation of Akt by rapamycin (represented by broken lines).</div></div>